𝔖 Bobbio Scriptorium
✦   LIBER   ✦

4510 POSTER A phase 2 trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): updated results and analysis of circulating biomarkers

✍ Scribed by Hutson, T.E.; George, D.J.; Michaelson, M.D.; Rosenberg, J.E.; Bukowski, R.M.; Sosman, J.A.; Stadler, W.M.; Margolin, K.; Rini, B.I.


Book ID
121381946
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
65 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES